Liphorus Pharmaceuticals announces financing of $6.4 million to support development of small molecules inhibitors targeting PCSK9 for the treatment of hypercholesterolemia November 11, 2014 Read more
Creation of Liphorus Pharmaceuticals A significant investment in healthcare in Montréal November 11, 2014 Read more
